M/S .pharma Associates, Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: M/S .pharma Associates, Pharmaceutical Import Records from India — 5 Products, $2.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/S .pharma Associates, — Pharmaceutical Importer Profile (2026) | 5 Products, $2.2M Trade | TransData Nexus

M/S .pharma Associates,

Pharmaceutical Importer · Sri Lanka · CNS & Psychiatric Focus · $2.2M Total Trade · DGFT Verified

M/S .pharma Associates, is a pharmaceutical importer based in Sri Lanka with a total trade value of $2.2M across 5 products in 4 therapeutic categories. Based on 72 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M/S .pharma Associates, sources from 3 verified Indian suppliers, with The Madras Pharmaceuticals accounting for 58.0% of imports.

M/S .pharma Associates, — Import Portfolio & Supplier Network

M/S .pharma Associates, import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/S .pharma Associates,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
The Madras Pharmaceuticals	$2.5M	153	58.0%
The Madras Pharmaceutical	$1.6M	62	36.8%
Softgel Healthcare Private Limited

What Formulations Does M/S .pharma Associates, Import?

Formulation	Value	Ships
Tab.ranosin (ranolazine extended	$491.7K	17
Cap.gabanin 100 (gabapentin capsules	$367.6K	15
Ranosin (ranolazine extended release tablets 500 MG)	$223.1K	6
Cap.gabanin 300 (gabapentin capsules	$220.6K	9
Cap.pregab 150 (pregabalin capsules	$204.3K	7
Tab.clopid (clopidogrel tablets USP 75	$203.1K	7
Tab.nicodil 10 (nicorandil tablets 10 MG	$166.5K	9
Nicodil 10 (nicorandil tablets 10 MG)	$160.5K	7
Tab.atorfit 20 (atorvastatin tablets	$144.2K	5
Tab.tiglor (ticagrelor tablets 90 MG)	$128.4K	3
Tab.tiglor (ticagrelor tablets 90 MG)	$102.7K	3
Gabanin 100 (gabapentin capsules USP 100MG)	$91.3K	2
Emitop (domperidone tablets BP 10 MG)(1x500`s)	$85.6K	3
Lazo (sulfasalazine delayed release	$73.1K	2
Tiglor (ticagrelor tablets 90 MG)	$69.2K	4

M/S .pharma Associates, imports 96 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Gabapentin	CNS & Psychiatric	$1.5M	30	0.2%	12
2	Domperidone	Gastrointestinal	$315.5K	16	1.1%	12
3	Miconazole	Antifungals	$162.0K	15	0.8%	17
4	Sulfasalazine	Gastrointestinal	$155.1K	7	4.8%	5
5	Acarbose	Advanced Diabetes Medications	$52.8K	4	0.8%	12

M/S .pharma Associates, imports 5 pharmaceutical products across 4 categories into Sri Lanka totaling $2.2M.

M/S .pharma Associates, — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/S .pharma Associates is a specialty pharmaceutical company based in Colombo, Sri Lanka, focusing on the importation and distribution of finished pharmaceutical formulations across various therapeutic areas. Established in 1990, the company has developed a robust presence in the Sri Lankan pharmaceutical market, emphasizing the sales and market development of products in fields such as Cardiology, Oncology, Gastroenterology, Obstetrics & Gynaecology, Neurology, Paediatrics, Endocrinology, and Rheumatology. (pharmasl.lk)

The company operates as a pharmaceutical importer and distributor, sourcing finished pharmaceutical formulations from international suppliers, particularly from India. M/S .pharma Associates plays a significant role in Sri Lanka's pharmaceutical distribution network, ensuring the availability of a diverse range of medications to meet the healthcare needs of the population. Their portfolio includes specialized products such as biosimilars, oncology medications, ASD catheters, and cardiac stents, reflecting a commitment to providing advanced therapeutic options. (pharmasl.lk)

2Distribution Network

M/S .pharma Associates has established an extensive distribution network throughout Sri Lanka, encompassing major cities and regional centers. Their distribution network includes partnerships with local distributors in Colombo, Wellawatte Drugs and Peoples Medicals, as well as in suburbs like Nega Marketing Services and Harsha Distributors. Additionally, they have branches in Kurunegala, Akkaraipattu, Jaffna, Galle, and Kandy, ensuring comprehensive coverage across the island. (pharmasl.lk)

The company's logistics capabilities are designed to facilitate efficient delivery of pharmaceutical products to various healthcare providers, including hospitals, clinics, and pharmacies. By leveraging their own distribution network and collaborating with local partners, M/S .pharma Associates ensures timely and reliable access to essential medications, thereby supporting the healthcare infrastructure in Sri Lanka.

3Industry Role

M/S .pharma Associates functions primarily as a pharmaceutical importer and distributor within Sri Lanka's pharmaceutical supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company ensures a steady supply of essential medications to meet the diverse healthcare needs of the Sri Lankan population. Their focus on specialized products, such as biosimilars and oncology medications, positions them as a key player in providing advanced therapeutic options in the market. (pharmasl.lk)

Through their extensive distribution network and strategic partnerships, M/S .pharma Associates plays a crucial role in bridging the gap between international pharmaceutical manufacturers and local healthcare providers, thereby contributing to the overall health and well-being of the community.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/S .pharma Associates,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

M/S .pharma Associates demonstrates a high level of sourcing concentration, with a significant portion of their pharmaceutical imports originating from a select group of Indian suppliers. The top three suppliers are:

THE MADRAS PHARMACEUTICALS: $2.5 million (153 shipments, 58.0%)
THE MADRAS PHARMACEUTICAL: $1.6 million (62 shipments, 36.8%)
SOFTGEL HEALTHCARE PRIVATE LIMITED: $221,000 (11 shipments, 5.1%)

This concentration indicates a strategic choice by M/S .pharma Associates to establish strong, long-term relationships with these suppliers, ensuring consistent product quality and supply reliability. The substantial number of shipments from these suppliers suggests a stable and ongoing partnership, which is crucial for maintaining the continuity of pharmaceutical supplies in the Sri Lankan market.

However, such concentration also presents potential risks, including supply chain disruptions if any of these suppliers face operational challenges. To mitigate these risks, M/S .pharma Associates may consider diversifying their supplier base and exploring partnerships with additional manufacturers to enhance supply chain resilience.

Supply Chain Resilience

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

In Sri Lanka, the National Medicines Regulatory Authority (NMRA) serves as the primary regulatory body overseeing the pharmaceutical sector. Established under the NMRA Act No. 05 of 2015, the NMRA is responsible for ensuring the availability of efficacious, safe, and good-quality medicines to the public at affordable prices.

The NMRA's regulatory framework encompasses the evaluation, registration, and monitoring of medicinal products, medical devices, and related health products. This includes the assessment of product quality, efficacy, safety, and compliance with international standards. The Medicines Evaluation Committee (MEC), formed under the NMRA Act, conducts scientific and technical reviews, inspections, and surveillance activities to uphold these standards.

2Import Licensing & GMP

To import pharmaceutical products into Sri Lanka, companies must obtain the necessary import licenses from the NMRA. This process involves submitting detailed product information, including Certificates of Pharmaceutical Product (COPP), Certificates of Analysis (COA), Batch Release Certificates, and Product Registration Certificates, as applicable.

The NMRA recognizes Good Manufacturing Practice (GMP) certifications from reputable international bodies, such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certifications from these recognized authorities to comply with Sri Lankan regulations. (freyrsolutions.com.lk)

M/S .pharma Associates, — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

M/S .pharma Associates' product strategy focuses on therapeutic areas with significant demand in the Sri Lankan market, including Cardiology, Oncology, Gastroenterology, Obstetrics & Gynaecology, Neurology, Paediatrics, Endocrinology, and Rheumatology. By importing specialized products such as biosimilars, oncology medications, ASD catheters, and cardiac stents, the company addresses critical healthcare needs and positions itself as a provider of advanced therapeutic options. (pharmasl.lk)

The company's emphasis on these therapeutic areas aligns with the growing healthcare demands in Sri Lanka, driven by an aging population and increasing prevalence of chronic diseases. By focusing on these segments, M/S .pharma Associates aims to enhance

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — M/S .pharma Associates,

What products does M/S .pharma Associates, import from India?

M/S .pharma Associates, imports 5 pharmaceutical products across 4 categories. Top imports: Gabapentin ($1.5M), Domperidone ($315.5K), Miconazole ($162.0K), Sulfasalazine ($155.1K), Acarbose ($52.8K).

Who supplies pharmaceuticals to M/S .pharma Associates, from India?

M/S .pharma Associates, sources from 3 verified Indian suppliers. The primary supplier is The Madras Pharmaceuticals (58.0% of imports, $2.5M).

What is M/S .pharma Associates,'s total pharmaceutical import value?

M/S .pharma Associates,'s total pharmaceutical import value from India is $2.2M, based on 72 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/S .pharma Associates, focus on?

M/S .pharma Associates, imports across 4 categories. The largest: CNS & Psychiatric (68.6%), Gastrointestinal (21.5%), Antifungals (7.4%).

Get Full M/S .pharma Associates, Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.